<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00744835</url>
  </required_header>
  <id_info>
    <org_study_id>AFI-20</org_study_id>
    <nct_id>NCT00744835</nct_id>
  </id_info>
  <brief_title>Atrial Fibrillation Ablation Pilot Study</brief_title>
  <official_title>Atrial Fibrillation Ablation Pilot Study- Study Number AFI-20</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiac Rhythm and Heart Failure</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiac Rhythm and Heart Failure</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, non-randomized, multicenter, multi-country pilot study to evaluate the&#xD;
      safety and effectiveness of the Ablation Frontiers Cardiac Ablation System for the ablative&#xD;
      treatment of symptomatic permanent atrial fibrillation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study shall be conducted according to ISO 14155. Results of this research study will be&#xD;
      used to assess the performance and safety of the System and its components. Data may be&#xD;
      combined with similar research at additional sites to create a greater understanding of the&#xD;
      endpoints. Up to sixty (60) patients (including &quot;roll-in&quot; or training patients) will be&#xD;
      enrolled in a non-randomized study to assess the safety and efficacy of the Ablation&#xD;
      Frontiers Cardiac Ablation System. Further studies may be performed to gather additional data&#xD;
      regarding the safety and efficacy of the system.&#xD;
&#xD;
      Patients with a history of symptomatic permanent AF, willing and able to sign an informed&#xD;
      consent, and meeting all inclusion/exclusion criteria, as identified by the clinical&#xD;
      investigator, will be enrolled in the study. Comparative and descriptive statistics will be&#xD;
      used to summarize patient outcomes for the specified study endpoints.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">August 2007</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The acute/chronic safety endpoint is recording of all Severe Adverse Events (device and procedure related) followed for six months.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Effectiveness</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ablation Management</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ablation procedure and/or cardioversion</intervention_name>
    <description>Ablation Frontiers Cardiac Ablation System</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of symptomatic permanent atrial fibrillation&#xD;
&#xD;
          -  Age between 18 and 70&#xD;
&#xD;
          -  Willingness, ability and commitment to participate in baseline and follow-up&#xD;
             evaluations for the full length of the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Structural heart disease of clinical significance&#xD;
&#xD;
          -  Any prior ablation for atrial fibrillation&#xD;
&#xD;
          -  Prior ablation for arrhythmias other than AF within the past three months&#xD;
&#xD;
          -  Enrollment in any other ongoing arrhythmia study protocol&#xD;
&#xD;
          -  Any ventricular tachyarrhythmias currently being treated where the arrhythmia or the&#xD;
             management may interfere with this study&#xD;
&#xD;
          -  Active infection or sepsis&#xD;
&#xD;
          -  Any history of cerebral vascular disease including stroke or TIAs&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Left atrial thrombus at the time of ablation&#xD;
&#xD;
          -  Untreatable allergy to contrast media&#xD;
&#xD;
          -  Any diagnosis of AF secondary to electrolyte imbalance, thyroid disease, or any other&#xD;
             reversible or non-cardiovascular causes&#xD;
&#xD;
          -  History of blood clotting (bleeding or thrombotic) abnormalities&#xD;
&#xD;
          -  Known sensitivities to heparin or warfarin&#xD;
&#xD;
          -  Severe COPD (identified by an FEV1 &lt; 1)&#xD;
&#xD;
          -  Severe comorbidity or poor general physical/mental health that, in the opinion of the&#xD;
             investigator, will not allow the patient to be a good study candidate (i.e. other&#xD;
             disease processes, mental capacity, substance abuse, shortened life expectance, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. Antonius Ziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinic im Park</name>
      <address>
        <city>ZÃ¼rich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Papworth Hospital</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George's University of London</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.ablationfrontiers.com</url>
    <description>Company website</description>
  </link>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>August 28, 2008</study_first_submitted>
  <study_first_submitted_qc>August 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2008</study_first_posted>
  <last_update_submitted>September 17, 2018</last_update_submitted>
  <last_update_submitted_qc>September 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

